Atlas Trials

University of Michigan Rogel Cancer Center

320 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch University of Michigan Rogel Cancer Center

RecordFirmDate
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen (NCT01457885)University of Michigan Rogel Cancer Center2011-11-01
Evaluation of Metformin, Targeting Cancer Stem Cells for Prevention of Relapse in Gynecologic Patients (NCT01579812)University of Michigan Rogel Cancer Center2011-10-01
Trial of Low-Dose Methotrexate and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma (NCT01389076)University of Michigan Rogel Cancer Center2011-07-01
A Trial of Gemcitabine, Infusional 5-Fluorouracil and Cisplatin for Advanced Pancreatic and Biliary Cancers (NCT01661114)University of Michigan Rogel Cancer Center2011-07-01
A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients (NCT01661088)University of Michigan Rogel Cancer Center2011-06-01
A Multi-Centered Trial Evaluating the Role of Vitamin D Metabolism in Non-Small Cell Lung Cancer (NCT01409681)University of Michigan Rogel Cancer Center2011-05-01
Hypofractionated Stereotactic Body Radiation Therapy (SBRT) (NCT01288534)University of Michigan Rogel Cancer Center2011-01-01
Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients (NCT01663259)University of Michigan Rogel Cancer Center2011-01-01
Palonosetron for the Treatment of Nausea and Vomiting in Terminally Ill Patients (NCT00982995)University of Michigan Rogel Cancer Center2010-11-01
A Study of AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and Neck (NCT01285635)University of Michigan Rogel Cancer Center2010-06-01
Benefits of Exercise Training in Head and Neck Cancer Patients Undergoing Organ-Preserving Definitive Therapy (NCT01794481)University of Michigan Rogel Cancer Center2010-01-01
A Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic Cancer (NCT01522937)University of Michigan Rogel Cancer Center2009-10-01
Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Cancer (NCT00995488)University of Michigan Rogel Cancer Center2009-10-01
Carfilzomib and Lenalidomide With Dexamethasone Combination in Newly Diagnosed, Previously Untreated Multiple Myeloma (NCT01029054)University of Michigan Rogel Cancer Center2009-09-01
Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancer (NCT01896050)University of Michigan Rogel Cancer Center2009-09-01
Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer Patients (NCT01814397)University of Michigan Rogel Cancer Center2009-07-01
Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-Alpha (NCT01073436)University of Michigan Rogel Cancer Center2009-05-01
Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (SCC) (NCT00904345)University of Michigan Rogel Cancer Center2009-04-01
Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant (NCT00639717)University of Michigan Rogel Cancer Center2009-03-01
Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer: Concordance Study (NCT00858585)University of Michigan Rogel Cancer Center2009-03-01
A Study Using Cone Beam CT for Head and Neck Cancer (NCT01661062)University of Michigan Rogel Cancer Center2009-01-01
Phase I/II Calcitriol in Lung Cancer (NCT00794547)University of Michigan Rogel Cancer Center2008-12-01
Trial Of Double Umbilical Cord Blood Transplantation (NCT00763490)University of Michigan Rogel Cancer Center2008-12-01
Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients With Aromatase-Inhibitor Associated Pain (NCT01028352)University of Michigan Rogel Cancer Center2008-10-01
Using FDG-PET During Radiation Therapy in Non-Small Cell Lung Cancer (NCT01190527)University of Michigan Rogel Cancer Center2008-08-01
A Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary Single Photon Emission Tomography (SPECT) (NCT01519232)University of Michigan Rogel Cancer Center2008-08-01
A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced Sarcoma (NCT00743509)University of Michigan Rogel Cancer Center2008-08-01
Use of Trastuzumab to Induce Increased ER Expression in ER-negative/Low, Her-2/Neu Positive Breast Cancer (NCT00726180)University of Michigan Rogel Cancer Center2008-07-01
The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease (NCT00726375)University of Michigan Rogel Cancer Center2008-05-01
A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response (NCT01209962)University of Michigan Rogel Cancer Center2008-05-01
Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma (NCT00724568)University of Michigan Rogel Cancer Center2008-05-01
Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma (NCT00644696)University of Michigan Rogel Cancer Center2008-04-01
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer (NCT00645593)University of Michigan Rogel Cancer Center2008-03-01
A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer. (NCT00637390)University of Michigan Rogel Cancer Center2008-03-01
Phase I/II Study of MK-0752 Followed by Docetaxel in Advanced or Metastatic Breast Cancer (NCT00645333)University of Michigan Rogel Cancer Center2008-03-01
Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen (NCT00615589)University of Michigan Rogel Cancer Center2008-02-01
Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer (NCT00585689)University of Michigan Rogel Cancer Center2007-12-01
Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen (NCT00556452)University of Michigan Rogel Cancer Center2007-10-01
Imatinib or Nilotinib With Pegylated Interferon-α2b in Chronic Myeloid Leukemia (NCT00573378)University of Michigan Rogel Cancer Center2007-09-01
Sunitinib Maintenance Therapy After Induction Platinum-Based Chemotherapy in Patients With ES-SCLC (NCT00616109)University of Michigan Rogel Cancer Center2007-09-01
Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE) (NCT00599131)University of Michigan Rogel Cancer Center2007-08-01
Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure (NCT00555477)University of Michigan Rogel Cancer Center2007-08-01
Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma (NCT00570531)University of Michigan Rogel Cancer Center2007-06-01
Early Assessment of Treatment Response Using Functional Diffusion Mapping (NCT02064283)University of Michigan Rogel Cancer Center2007-05-01
Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer (NCT00603057)University of Michigan Rogel Cancer Center2007-05-01
Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies. (NCT00565227)University of Michigan Rogel Cancer Center2007-04-01
Study of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic Cancer (NCT00456599)University of Michigan Rogel Cancer Center2007-04-01
A Study of Radiation Toxicity in the Liver Using MRI-Based Perfusion (NCT01210027)University of Michigan Rogel Cancer Center2007-03-01
Salvage Radiation Therapy and Taxotere for PSA Failure After Radical Prostatectomy (NCT00480857)University of Michigan Rogel Cancer Center2007-03-01
Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia (NCT00623935)University of Michigan Rogel Cancer Center2007-03-01
Pilot Study of dMRI as a Tool for Early Evaluation of Tumor Response in Diffuse Large B-cell Lymphoma (NCT00645359)University of Michigan Rogel Cancer Center2006-11-01
A Pilot Study Assessing Intra-Metastasis Administration of Autologous KLH-pulsed Dendritic Cells With Tumoral Radiation Therapy in Patients With Metastatic Pancreatic Carcinoma (NCT00843830)University of Michigan Rogel Cancer Center2006-10-01
Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer (NCT00593866)University of Michigan Rogel Cancer Center2006-06-01
Imaging Biomarker for Early Detection of Treatment Efficacy During Breast Cancer Neoadjuvant Chemotherapy (NCT02679586)University of Michigan Rogel Cancer Center2006-06-01
A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation (NCT00405327)University of Michigan Rogel Cancer Center2006-06-01
Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma (NCT00393796)University of Michigan Rogel Cancer Center2006-05-01
A Randomized Comparison of Radiation Therapy Techniques in the Management of Node Positive Breast Cancer (NCT00581256)University of Michigan Rogel Cancer Center2006-04-01
Cross-Sectional Study of Oral Health in Patients After Parotid-Sparing Radiation Therapy for Head and Neck Cancer (NCT01663246)University of Michigan Rogel Cancer Center2006-04-01
A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer (NCT00399321)University of Michigan Rogel Cancer Center2006-04-01
A Study of Mitomycin C, Irinotecan, and Cetuximab (NCT00271011)University of Michigan Rogel Cancer Center2005-12-01
Tamoxifen Citrate Decision Aids for Women at Increased Risk of Breast Cancer (NCT00967824)University of Michigan Rogel Cancer Center2005-10-01
Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma Esophagus (NCT00239200)University of Michigan Rogel Cancer Center2005-10-01
Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple Myeloma (NCT00135200)University of Michigan Rogel Cancer Center2005-08-01
Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate Cancer (NCT00134355)University of Michigan Rogel Cancer Center2005-07-01
Treatment for Patients With Metastatic Thyroid Cancer (NCT00176748)University of Michigan Rogel Cancer Center2005-07-01
Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma (NCT00116961)University of Michigan Rogel Cancer Center2005-06-01
Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas (NCT00148109)University of Michigan Rogel Cancer Center2005-06-01
Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast Cancer (NCT00161265)University of Michigan Rogel Cancer Center2005-05-01
Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer (NCT00156273)University of Michigan Rogel Cancer Center2005-04-01
MRI Study of Changes in Blood-Brain/Tumor-Barrier Permeability in Patients With Brain Metastases During and After Radiotherapy (NCT02031237)University of Michigan Rogel Cancer Center2005-04-01
Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling (NCT00161278)University of Michigan Rogel Cancer Center2004-12-01
Assessment Of Liver Function in Patients Undergoing Hepatic Irradiation (NCT01519219)University of Michigan Rogel Cancer Center2004-11-24
Vessel Sparing Prostate Radiation Therapy (NCT02958787)University of Michigan Rogel Cancer Center2004-11-01
Partial Breast Irradiation Using Accelerated Intensity Modulated Radiotherapy (NCT00581529)University of Michigan Rogel Cancer Center2004-11-01
MRI Study of Radiation-Induced Damage to White Matter and Blood-Brain-Barrier (NCT01988675)University of Michigan Rogel Cancer Center2004-08-26
Computer-Based Tailored or Standard Information for Colorectal Cancer Screening (NCT00955188)University of Michigan Rogel Cancer Center2004-08-01
Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma (NCT00189137)University of Michigan Rogel Cancer Center2004-08-01
Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT) (NCT00141739)University of Michigan Rogel Cancer Center2004-08-01
Study of Combination Therapy With VELCADE, Doxil, and Dexamethasone (VDd) in Multiple Myeloma (NCT00135187)University of Michigan Rogel Cancer Center2004-07-01
Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer (NCT00242190)University of Michigan Rogel Cancer Center2004-06-01
Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma (NCT00115739)University of Michigan Rogel Cancer Center2004-02-01
The Use of Etanercept (Enbrel®) in the Treatment of Acute Graft-Versus-Host Disease (NCT00141713)University of Michigan Rogel Cancer Center2003-10-01
Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant (NCT00141726)University of Michigan Rogel Cancer Center2003-10-01
Optimized Intensity Modulated Irradiation for Head and Neck Cancer (NCT00580983)University of Michigan Rogel Cancer Center2003-08-01
Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine (NCT00156312)University of Michigan Rogel Cancer Center2003-07-01
Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer (NCT00230399)University of Michigan Rogel Cancer Center2003-06-01
UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer (NCT00064272)University of Michigan Rogel Cancer Center2003-05-01
Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant (NCT00143845)University of Michigan Rogel Cancer Center2003-04-01
Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancer (NCT00151047)University of Michigan Rogel Cancer Center2003-03-01
Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer (NCT00176813)University of Michigan Rogel Cancer Center2003-03-01
Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's Lymphoma (NCT00141700)University of Michigan Rogel Cancer Center2003-03-01
Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage (NCT00156260)University of Michigan Rogel Cancer Center2003-01-01
A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck Cancer (NCT00148122)University of Michigan Rogel Cancer Center2002-11-01
Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate (NCT00151073)University of Michigan Rogel Cancer Center2002-04-01
Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC (NCT00156286)University of Michigan Rogel Cancer Center2002-03-01
Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer (NCT00176735)University of Michigan Rogel Cancer Center2001-12-01
Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer (NCT00151086)University of Michigan Rogel Cancer Center2001-12-01
Curcumin for the Prevention of Colon Cancer (NCT00027495)University of Michigan Rogel Cancer Center2001-12-01
Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma (NCT00176800)University of Michigan Rogel Cancer Center2001-11-01
Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site (NCT00148135)University of Michigan Rogel Cancer Center2001-05-01
← Previous Next →

Track University of Michigan Rogel Cancer Center automatically

Every clearance here is in the API, with alerts when new ones post.